Skip to main content
Top
Published in: Surgical Endoscopy 8/2011

01-08-2011

Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis

Authors: Hsin Cheng, Yu-Ching Tsai, Wei-Ying Chen, Wei-Lun Chang, Hsiu-Chi Cheng, Bor-Shyang Sheu

Published in: Surgical Endoscopy | Issue 8/2011

Login to get access

Abstract

Background

We assessed whether the esophageal mucosa index of hemoglobin (IHb) could assist the Los Angeles (LA) classification in defining the severity of erosive reflux esophagitis (RE) and predicting the treatment response by esomeprazole.

Methods

Five hundred twenty-four subjects (424 RE and 100 controls) with normal body mass index and hemoglobin had undergone endoscopy to confirm the RE grade by LA classification and to check the series of IHb values at every centimeter of the esophageal mucosa while withdrawing the endoscope to above the esophageal–gastric junction (EGJ). The RE cases had received esomeprazole for 8 weeks (40 mg/day) to assess the cumulative proportions of sustained symptomatic response (SSR).

Results

The IHb value at the EGJ was higher in RE patients than in controls (P < 0.001). Selecting 70 as the cutoff IHb value at the EGJ, the efficacy to define RE achieved 95.8% (406/424) sensitivity and 94% (94/100) specificity. For the patients with same the LA grade, the length of IHb value >70 above the EGJ (L-IHb70) that is greater than 4 cm correlated with a poor cumulative rate of SSR (P < 0.01).

Conclusion

The IHb value >70 at the EGJ is a reliable indicator of RE. The L-IHb70 can serve as a supplementary indicator to predict the response to esomeprazole index within the same LA grade.
Literature
1.
go back to reference Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MC, Kuipers EJ (2006) Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 24:377–385PubMedCrossRef Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MC, Kuipers EJ (2006) Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 24:377–385PubMedCrossRef
2.
3.
go back to reference Yang HB, Sheu BS, Wang ST, Cheng HC, Chang WL, Chen WY (2009) H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole. Am J Gastroenterol 104:1642–1649PubMedCrossRef Yang HB, Sheu BS, Wang ST, Cheng HC, Chang WL, Chen WY (2009) H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole. Am J Gastroenterol 104:1642–1649PubMedCrossRef
4.
go back to reference Spechler SJ (1992) Epidemiology and natural history of gastroesophageal reflux disease. Digestion 51(Suppl 4):3s–7s Spechler SJ (1992) Epidemiology and natural history of gastroesophageal reflux disease. Digestion 51(Suppl 4):3s–7s
5.
go back to reference Chiba N, De Gara CJ, Wilkinson JM, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798–1810PubMedCrossRef Chiba N, De Gara CJ, Wilkinson JM, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798–1810PubMedCrossRef
6.
go back to reference Richardson P, Hawkey CJ, Stack WA (1998) Proton pump inhibitors. pharmacology and rationale for use in gastrointestinal disorders. Drugs 56:307–335PubMedCrossRef Richardson P, Hawkey CJ, Stack WA (1998) Proton pump inhibitors. pharmacology and rationale for use in gastrointestinal disorders. Drugs 56:307–335PubMedCrossRef
7.
8.
go back to reference Holloway RH, Dent J, Narielvala F, Mackinnon AM (1996) Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux esophagitis. Gut 38:649–654PubMedCrossRef Holloway RH, Dent J, Narielvala F, Mackinnon AM (1996) Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux esophagitis. Gut 38:649–654PubMedCrossRef
9.
go back to reference Dent J, Brun J, Fendrick A, Fennerty M, Janssens J, Kahrilas P, Lauritsen K, Reynolds J, Shaw M, Talley N (1999) An evidence-based appraisal of reflux disease management—the Genval workshop report. Gut 44:S1–S16CrossRef Dent J, Brun J, Fendrick A, Fennerty M, Janssens J, Kahrilas P, Lauritsen K, Reynolds J, Shaw M, Talley N (1999) An evidence-based appraisal of reflux disease management—the Genval workshop report. Gut 44:S1–S16CrossRef
10.
go back to reference Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172–180PubMedCrossRef Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172–180PubMedCrossRef
11.
go back to reference Chen WY, Chang WL, Tsai YC, Cheng HC, Lu CC, Sheu BS (2010) Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B. Am J Gastroenterol 105:1046–1052PubMedCrossRef Chen WY, Chang WL, Tsai YC, Cheng HC, Lu CC, Sheu BS (2010) Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B. Am J Gastroenterol 105:1046–1052PubMedCrossRef
12.
go back to reference Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O (2001) Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of “on-demand’ therapy for 6 months. Aliment Pharmacol Ther 15:347–354PubMedCrossRef Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O (2001) Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of “on-demand’ therapy for 6 months. Aliment Pharmacol Ther 15:347–354PubMedCrossRef
13.
go back to reference Sheu BS, Cheng HC, Chang WL, Chen WY, Kao AW (2007) The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis. Am J Gastroenterol 102:2387–2394PubMedCrossRef Sheu BS, Cheng HC, Chang WL, Chen WY, Kao AW (2007) The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis. Am J Gastroenterol 102:2387–2394PubMedCrossRef
14.
go back to reference Sheu BS, Chang WL, Cheng HC, Kao AW, Lu CC (2008) Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole. Am J Gastroenterol 103:2209–2214PubMedCrossRef Sheu BS, Chang WL, Cheng HC, Kao AW, Lu CC (2008) Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole. Am J Gastroenterol 103:2209–2214PubMedCrossRef
15.
go back to reference Tsuji S, Sato N, Kawano S, Kamada T (1988) Functional imaging for the analysis of the mucosal blood hemoglobin distribution using electronic endoscopy. Gastrointest Endosc 34:332–336PubMedCrossRef Tsuji S, Sato N, Kawano S, Kamada T (1988) Functional imaging for the analysis of the mucosal blood hemoglobin distribution using electronic endoscopy. Gastrointest Endosc 34:332–336PubMedCrossRef
16.
go back to reference Tsuji S, Kawano S, Hayashi N, Tsujii M, Ogihara T, Kamada T, Sato N (1991) Analysis of mucosal blood hemoglobin distribution in gastric ulcers by computerized color display on electronic endoscopy. Endoscopy 23:321–324PubMedCrossRef Tsuji S, Kawano S, Hayashi N, Tsujii M, Ogihara T, Kamada T, Sato N (1991) Analysis of mucosal blood hemoglobin distribution in gastric ulcers by computerized color display on electronic endoscopy. Endoscopy 23:321–324PubMedCrossRef
17.
go back to reference Yao K, Yao T, Matsui T, Iwashita A, Oishi T (2000) Hemoglobin content in intramucosal gastric carcinoma as a marker of histologic differentiation: a clinical application of quantitative electronic endoscopy. Gastrointest Endosc 52:241–245PubMedCrossRef Yao K, Yao T, Matsui T, Iwashita A, Oishi T (2000) Hemoglobin content in intramucosal gastric carcinoma as a marker of histologic differentiation: a clinical application of quantitative electronic endoscopy. Gastrointest Endosc 52:241–245PubMedCrossRef
18.
go back to reference Kuroda M, Ida K, Tsuboi H (2001) Application of hemoglobin index in diagnosis of Helicobacter pylori eradication. Clin Gastroenterol 16:1533–1538 Kuroda M, Ida K, Tsuboi H (2001) Application of hemoglobin index in diagnosis of Helicobacter pylori eradication. Clin Gastroenterol 16:1533–1538
19.
go back to reference Ida K, Kuroda M, Tsuboi H (2001) Diagnosis of Helicobacter pylori infection by combined endoscopic methods. Clin Gastroenterol 16:1539–1546 Ida K, Kuroda M, Tsuboi H (2001) Diagnosis of Helicobacter pylori infection by combined endoscopic methods. Clin Gastroenterol 16:1539–1546
20.
go back to reference Nakagawa S, Kato M, Shimizu Y, Nakagawa M, Yamamoto J, Luis PA, Kodaira J, Kawarasaki M, Takeda H, Sugiyama T, Asaka M (2003) Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy. Gastrointest Endosc 58:71–75PubMedCrossRef Nakagawa S, Kato M, Shimizu Y, Nakagawa M, Yamamoto J, Luis PA, Kodaira J, Kawarasaki M, Takeda H, Sugiyama T, Asaka M (2003) Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy. Gastrointest Endosc 58:71–75PubMedCrossRef
21.
go back to reference Kim GH, Kim KB, Lim EK, Choi SH, Kim TO, Heo J, Kang DH, Song GA, Cho M, Park DY (2006) Analysis of endoscopic electronic image of intramucosal gastric carcinoma using a software program for calculating hemoglobin index. J Korean Med Sci 21:1041–1047PubMedCrossRef Kim GH, Kim KB, Lim EK, Choi SH, Kim TO, Heo J, Kang DH, Song GA, Cho M, Park DY (2006) Analysis of endoscopic electronic image of intramucosal gastric carcinoma using a software program for calculating hemoglobin index. J Korean Med Sci 21:1041–1047PubMedCrossRef
22.
go back to reference Yao K, Oishi T, Matsui T, Yao T, Iwashita A (2002) Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc 56:279–284PubMedCrossRef Yao K, Oishi T, Matsui T, Yao T, Iwashita A (2002) Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc 56:279–284PubMedCrossRef
23.
go back to reference Yao K, Kato M, Fujisaki J (2005) Techniques using the hemoglobin index of the gastric mucosa. Endoscopy 37:479–486PubMedCrossRef Yao K, Kato M, Fujisaki J (2005) Techniques using the hemoglobin index of the gastric mucosa. Endoscopy 37:479–486PubMedCrossRef
24.
go back to reference Igarashi M, Saitoh Y, Fujii T (2005) Adaptive index of hemoglobin color enhancement for the diagnosis of colorectal disease. Endoscopy 37:386–388PubMedCrossRef Igarashi M, Saitoh Y, Fujii T (2005) Adaptive index of hemoglobin color enhancement for the diagnosis of colorectal disease. Endoscopy 37:386–388PubMedCrossRef
25.
go back to reference Kobayashi K, Igarashi M, Sara M, Yokoyama K, Saigenji K (2002) Clinical significance of adaptive index of hemoglobin color enhancement for endoscopic diagnosis of superficial type colorectal tumors. Dig Endosc 14(Suppl):S51–S53CrossRef Kobayashi K, Igarashi M, Sara M, Yokoyama K, Saigenji K (2002) Clinical significance of adaptive index of hemoglobin color enhancement for endoscopic diagnosis of superficial type colorectal tumors. Dig Endosc 14(Suppl):S51–S53CrossRef
26.
go back to reference Fujii T, Ono A (2002) Is adaptive index of hemoglobin color enhancement effective in detecting small depressed type colorectal cancers? Dig Endosc 14(Suppl):S58–S61CrossRef Fujii T, Ono A (2002) Is adaptive index of hemoglobin color enhancement effective in detecting small depressed type colorectal cancers? Dig Endosc 14(Suppl):S58–S61CrossRef
27.
go back to reference Shimizu S (2002) Color enhancement in colonoscopy may be effective for detection of superficial type colorectal tumors. Dig Endosc 14(Suppl):S62–S64CrossRef Shimizu S (2002) Color enhancement in colonoscopy may be effective for detection of superficial type colorectal tumors. Dig Endosc 14(Suppl):S62–S64CrossRef
28.
go back to reference Saitoh Y, Fujiya M, Watari J, Kohgo Y (2002) Magnifying colonoscopy findings by adapted index of hemoglobin enhancement image processing system in ulcerative colitis. Dig Endosc 14(Suppl):S54–S57CrossRef Saitoh Y, Fujiya M, Watari J, Kohgo Y (2002) Magnifying colonoscopy findings by adapted index of hemoglobin enhancement image processing system in ulcerative colitis. Dig Endosc 14(Suppl):S54–S57CrossRef
29.
go back to reference Fujiya M, Saitoh Y, Nomura M, Maemoto A, Fujiya K, Watari J, Ashida T, Ayabe T, Obara T, Kohgo Y (2002) Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 56:535–542PubMedCrossRef Fujiya M, Saitoh Y, Nomura M, Maemoto A, Fujiya K, Watari J, Ashida T, Ayabe T, Obara T, Kohgo Y (2002) Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 56:535–542PubMedCrossRef
30.
go back to reference Thitiphuree S, Talley NJ (2000) Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract 54:537–541PubMed Thitiphuree S, Talley NJ (2000) Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract 54:537–541PubMed
31.
go back to reference Andersson T, Rohss K, Bredberg E, Hassan-Alin M (2001) Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther 15:1563–1569PubMedCrossRef Andersson T, Rohss K, Bredberg E, Hassan-Alin M (2001) Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther 15:1563–1569PubMedCrossRef
32.
go back to reference Sheu BS, Kao AW, Cheng HC, Hunag SF, Chen TW, Lu CC, Wu JJ (2005) Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. Aliment Pharmacol Ther 21:283–288PubMedCrossRef Sheu BS, Kao AW, Cheng HC, Hunag SF, Chen TW, Lu CC, Wu JJ (2005) Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. Aliment Pharmacol Ther 21:283–288PubMedCrossRef
Metadata
Title
Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis
Authors
Hsin Cheng
Yu-Ching Tsai
Wei-Ying Chen
Wei-Lun Chang
Hsiu-Chi Cheng
Bor-Shyang Sheu
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 8/2011
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-010-1569-x

Other articles of this Issue 8/2011

Surgical Endoscopy 8/2011 Go to the issue

Letter--Reply

Author reply